Livongo Health, Inc. Reports Consolidated Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2019; Revises Earnings Guidance for the Year 2020; Provides Earnings Guidance for the First Quarter of 2020
For the year, revenue was $170,198,000 against $68,431,000 reported a year ago. Loss from operations was $60,381,000 against $34,995,000 reported a year ago. Net loss was $55,270,000 against $33,382,000 reported a year ago. Net loss per share attributable to common stockholders, basic and diluted was $1.09 against $2.02 reported a year ago.
For the year 2020, the company expects revenue to grow between 65% and 71% to the range of $280.0 million to $290.0 million, ahead of preliminary guidance of approximately $276.0 million.
For the first quarter of 2020, the company expects revenue in the range of $60.0 million to $62.0 million.